Lista de obras -

A Population-based Study of Chronic Eosinophilic Leukemia-Not Otherwise Specified in the United States

artículo científico publicado en 2020

A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone

scientific article published on 02 April 2018

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status

artículo científico publicado en 2018

A population-based study of chronic neutrophilic leukemia in the United States

artículo científico publicado en 2020

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis

artículo científico publicado en 2018

Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis.

artículo científico publicado en 2018

Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes

artículo científico publicado en 2020

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms

article

Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia

scientific article published on 20 March 2019

Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases.

artículo científico publicado en 2018

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts.

artículo científico publicado en 2018

Blast-phase chronic myelomonocytic leukemia: more than just semantics

scientific article published on 07 August 2018

Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia

artículo científico publicado en 2020

Characteristics of late transplant-associated thrombotic microangiopathy (TA-TMA) in patients who underwent allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2020

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management

artículo científico publicado en 2020

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management

scientific article published on 01 June 2018

Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience

artículo científico publicado en 2019

Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis

scientific article published on 11 March 2020

Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia

artículo científico publicado en 2020

Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients

scientific article published on 13 December 2019

Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients

artículo científico publicado en 2019

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

artículo científico publicado en 2018

Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey.

artículo científico publicado en 2017

Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP

scientific article published on 04 December 2019

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases

artículo científico publicado en 2018

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

scientific article published on 17 October 2018

Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients

article

Functional validation of TERT and TERC variants of uncertain significance in patients with short telomere syndromes

artículo científico publicado en 2020

Genotype-Phenotype Correlation of Hereditary Erythrocytosis Mutations, a single center experience

artículo científico publicado en 2018

Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

artículo científico publicado en 2019

Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

artículo científico publicado en 2018

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

artículo científico publicado en 2020

Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes

scientific article published on 09 October 2018

Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients

artículo científico publicado en 2020

Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia

artículo científico publicado en 2020

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study.

artículo científico publicado en 2014

Monocytosis in polycythemia vera: Clinical and molecular correlates.

artículo científico publicado en 2017

Multiple isodicentric Y chromosomes in myeloid malignancies: a unique cytogenetic entity and potential therapeutic target

artículo científico publicado en 2018

Mutations and karyotype predict treatment response in myelodysplastic syndromes

scientific article published on 30 September 2018

Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model

artículo científico publicado en 2018

Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates

artículo científico publicado en 2018

Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia

artículo científico publicado en 2018

Outcome of elderly patients after failure to hypomethylating agents given as frontline therapy for acute myeloid leukemia: Single institution experience.

artículo científico publicado en 2017

PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia

scientific article published on 12 October 2019

Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients

scientific article published on 10 January 2020

Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study

artículo científico publicado en 2019

Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia

scientific article published on 16 August 2019

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm

scientific article published on 17 October 2018

Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia

artículo científico publicado en 2018

Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies

scientific article published on 05 February 2020

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.

artículo científico publicado en 2018

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia

artículo científico publicado en 2020

Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts

artículo científico publicado en 2018

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

scientific article published on 02 May 2019

QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia

scientific article published on 12 July 2019

RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis

artículo científico publicado en 2021

Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management"

artículo científico publicado en 2019

Risk of relapse in patients receiving azithromycin after allogeneic HSCT

artículo científico publicado en 2020

Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy.

artículo científico publicado en 2017

Special Considerations in the Management of Patients with Myelodysplastic Syndrome / Myeloproliferative Neoplasm Overlap Syndromes During the SARS-CoV-2 Pandemic

scientific article published on 30 April 2020

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

scientific article published on 18 June 2020

Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations in MDS/MPN overlap neoplasms

scientific article published on 14 February 2020

Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patients

artículo científico publicado en 2018

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

artículo científico publicado en 2019

Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.

artículo científico publicado en 2017

Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.

artículo científico publicado en 2017

The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS

artículo científico publicado en 2018

The importance of FLT3 mutational analysis in acute myeloid leukemia.

artículo científico publicado en 2017

Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.

artículo científico publicado en 2017

Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis

artículo científico publicado en 2021

U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates

artículo científico publicado en 2018

Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients

artículo científico publicado en 2020

Lista de obras de

A Population-based Study of Chronic Eosinophilic Leukemia-Not Otherwise Specified in the United States

A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status

A population-based study of chronic neutrophilic leukemia in the United States

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis

Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis.

Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms

Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia

Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases.

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts.

Blast-phase chronic myelomonocytic leukemia: more than just semantics

Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia

Characteristics of late transplant-associated thrombotic microangiopathy (TA-TMA) in patients who underwent allogeneic hematopoietic stem cell transplantation

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management

Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience

Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis

Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia

Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients

Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey.

Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients

Functional validation of TERT and TERC variants of uncertain significance in patients with short telomere syndromes

Genotype-Phenotype Correlation of Hereditary Erythrocytosis Mutations, a single center experience

Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes

Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients

Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study.

Monocytosis in polycythemia vera: Clinical and molecular correlates.

Multiple isodicentric Y chromosomes in myeloid malignancies: a unique cytogenetic entity and potential therapeutic target

Mutations and karyotype predict treatment response in myelodysplastic syndromes

Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model

Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates

Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia

Outcome of elderly patients after failure to hypomethylating agents given as frontline therapy for acute myeloid leukemia: Single institution experience.

PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia

Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients

Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study

Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm

Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia

Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia

Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia

RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis

Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management"

Risk of relapse in patients receiving azithromycin after allogeneic HSCT

Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy.

Special Considerations in the Management of Patients with Myelodysplastic Syndrome / Myeloproliferative Neoplasm Overlap Syndromes During the SARS-CoV-2 Pandemic

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations in MDS/MPN overlap neoplasms

Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patients

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.

Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.

The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS

The importance of FLT3 mutational analysis in acute myeloid leukemia.

Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.

Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis

U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates

Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients